Beijing, China – Sino Biological Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein. Sino Biological’s new […]

BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions (M&A). “We are thrilled to welcome Steve to the SomaLogic team,” said SomaLogic Chief Executive Officer Roy Smythe, M.D. “His extensive advisory and […]

CINCINNATI  — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021.  The Company is engaging an executive search firm in the recruitment of a new […]

FCDE to become the new majority shareholder of Bertin Technologies, today a subsidiary of the CNIM group, alongside the management team led by Bruno Vallayer. This new investment aims at supporting Bertin Technologies’ development to establish the group as a prominent independent equipment manufacturer and a consolidation plateform of advanced technologies. Paris FCDE announces the […]

Leadership from Luminex, Thermo Fisher Scientific, and Perkin Elmer join the IsoPlexis team BRANFORD, Conn. — IsoPlexis (NASDAQ: ISO), the leader in functional single-cell proteomics, today announced the appointment of Richard Rew as Senior VP, General Counsel and Secretary; Raj Khakhar as VP of Finance; and Manny Resendes as Global Controller. These three new appointments […]

SAN DIEGO — Agena Bioscience® (part of Mesa Labs’ Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences. This partnership will […]

CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that David Phillips, Chairman of the Board of Directors, will retire from the Board of Directors and not seek re-election when his term ends in January 2022.  The Board of Directors will elect […]

UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now starting the delivery of Olink® Signature Q100, facilitating hands-on access for researchers to Olink technology with a new benchtop system dedicated to multiplex protein biomarker measurement. Olink® Signature Q100 now offers a new solution designed for readout of Olink® Target and Olink® Focus […]

— Acquisition Will Add In Vivo Antibody Discovery Platform – — Conference Call at 8:00am ET — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it entered into a definitive agreement to acquire Abveris, (formally known as AbX Biologics, […]

Company broadens range of workflows in “Functional Cell Library” to accelerate cell therapy manufacturing and clinical studies BRANFORD, Conn. — IsoPlexis Corporation (NASDAQ: ISO), the leader in functional single-cell proteomics, today announced the publication of two high-impact clinical research studies in Nature Medicine. Both papers demonstrate the unique utility of IsoPlexis’ single-cell proteomic platform for predicting the potency […]